Using physiologically based pharmacokinetic modelling for in silico-in vitro-in vivo extrapolation to predict chemical exposure

被引：0
|
作者：
Lawless, M. [1 ]
Zhou, H. [1 ]
Fraczkiewicz, G. [1 ]
机构：
[1] Simulat Plus, Lancaster, CA USA
来源：
TOXICOLOGY LETTERS | 2016年 / 258卷
关键词：
D O I：
10.1016/j.toxlet.2016.06.1484
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P05-016
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro-In Vivo Extrapolation Model
    Siccardi, M.
    Almond, L.
    Schipani, A.
    Csajka, C.
    Marzolini, C.
    Wyen, C.
    Brockmeyer, N. H.
    Boffito, M.
    Owen, A.
    Back, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 494 - 502
  • [22] In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development Current Status and Future Directions
    Pelkonen, Olavi
    Turpeinen, Miia
    Raunio, Hannu
    CLINICAL PHARMACOKINETICS, 2011, 50 (08) : 483 - 491
  • [23] Understanding Receptor-Mediated Effects in Rainbow Trout: In Vitro-in Vivo Extrapolation Using Physiologically Based Toxicokinetic Models
    Brinkmann, Markus
    Eichbaum, Kathrin
    Buchinger, Sebastian
    Reifferscheid, Georg
    Thuy Bui
    Schaeffer, Andreas
    Hollert, Henner
    Preuss, Thomas G.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2014, 48 (06) : 3303 - 3309
  • [24] Response to "Ethnic-Specific In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Approaches to Predict Cytochrome P450-Mediated Pharmacokinetics in Chinese Population: Opportunities and Challenges"
    Barter, Zoe E.
    Tucker, Geoffrey T.
    Rowland-Yeo, Karen
    CLINICAL PHARMACOKINETICS, 2014, 53 (02) : 203 - 203
  • [25] Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability
    Cai, HL
    Stoner, C
    Reddy, A
    Freiwald, S
    Smith, D
    Winters, R
    Stankovic, C
    Surendran, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) : 133 - 139
  • [26] Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach
    Fei, Yang
    Kostewicz, Edmund S.
    Sheu, Ming-Thau
    Dressman, Jennifer B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 1274 - 1284
  • [27] Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 50 - 61
  • [28] In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned
    Algharably, Engi Abdelhady
    Di Consiglio, Emma
    Testai, Emanuela
    Pistollato, Francesca
    Mielke, Hans
    Gundert-Remy, Ursula
    FRONTIERS IN TOXICOLOGY, 2022, 4
  • [29] In Vitro-In Vivo Extrapolation Method to Predict Human Renal Clearance of Drugs
    Kunze, Annett
    Huwyler, Joerg
    Poller, Birk
    Gutmann, Heike
    Camenisch, Gian
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (03) : 994 - 1001
  • [30] A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance Concept
    Sugiyama, Yuichi
    Aoki, Yasunori
    DRUG METABOLISM AND DISPOSITION, 2023, 51 (09) : 1067 - 1076
12345